{"id":23630,"date":"2025-04-13T17:40:07","date_gmt":"2025-04-13T17:40:07","guid":{"rendered":"https:\/\/researchchemicalstore.eu\/?post_type=product&p=23630"},"modified":"2025-10-22T15:11:12","modified_gmt":"2025-10-22T15:11:12","slug":"noopept-20-mg-peletler","status":"publish","type":"product","link":"https:\/\/researchchemicalstore.eu\/tr\/urun\/noopept-20-mg-peletler\/","title":{"rendered":"NOOPEPT 20 MG Peletler"},"content":{"rendered":"

Noopept 20 MG Peletleri \u2013 Bilimsel \u00dcr\u00fcn A\u00e7\u0131klamas\u0131<\/span><\/span><\/strong><\/h3>\n

Genel bilgi<\/span><\/span><\/strong><\/h4>\n

Noopept (N-fenilasetil-L-prolilglisin etil ester)<\/span><\/span><\/strong> \u00a0bir\u00a0 <\/span><\/span>peptiderjik nootropik bile\u015fik<\/span><\/span><\/strong> \u00a0bili\u015fselli\u011fi geli\u015ftirici ve n\u00f6roprotektif potansiyel \u00f6zelliklere sahip. Bu peletler,\u00a0 <\/span><\/span>20 mg'l\u0131k standart doz<\/span><\/span><\/strong> \u00a0ve \u00f6zellikle form\u00fcle edilmi\u015ftir\u00a0 <\/span><\/span>bilimsel ara\u015ft\u0131rma<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n

Noopept \u015fu \u015fekilde \u00e7al\u0131\u015f\u0131r:\u00a0 <\/span><\/span>glutamat ve asetilkolin sistemlerinin mod\u00fclasyonu<\/span><\/span><\/strong> \u00a0ve bir\u00a0 <\/span><\/span>daha y\u00fcksek biyolojik aktivite<\/span><\/span><\/strong> \u00a0Geleneksel racetamlara g\u00f6re daha d\u00fc\u015f\u00fck dozajda.<\/span><\/span><\/p>\n

\n

Uygulamalar ve Ara\u015ft\u0131rma Alanlar\u0131<\/span><\/span><\/strong><\/h3>\n

Noopept'in \u015fu konulardaki olas\u0131 etkileri ara\u015ft\u0131r\u0131l\u0131yor:<\/span><\/span><\/p>\n

    \n
  1. \n

    Bili\u015fsel Geli\u015ftirme<\/span><\/span><\/strong> \u00a0\u2013 Haf\u0131zay\u0131, konsantrasyonu ve \u00f6\u011frenme yetene\u011fini geli\u015ftirebilir.<\/span><\/span><\/p>\n<\/li>\n

  2. \n

    N\u00f6roproteksiyon<\/span><\/span><\/strong> \u00a0\u2013 N\u00f6rodejenerasyona (\u00f6rne\u011fin Alzheimer, Parkinson) kar\u015f\u0131 potansiyel koruma sa\u011flad\u0131\u011f\u0131 ara\u015ft\u0131r\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/p>\n<\/li>\n

  3. \n

    Kayg\u0131 ve Duygudurum Mod\u00fclasyonu<\/span><\/span><\/strong> \u00a0\u2013 Preklinik modellerde kayg\u0131 giderici ve antidepresan etkileri olabilir.<\/span><\/span><\/p>\n<\/li>\n

  4. \n

    Sinaptik Plastisite<\/span><\/span><\/strong> \u00a0\u2013 Daha iyi n\u00f6ronal sa\u011fl\u0131k i\u00e7in BDNF ve NGF \u00fcretimini uyarabilir.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

    \u26a0\u00a0\u0130nsan kullan\u0131m\u0131 i\u00e7in onaylanmam\u0131\u015ft\u0131r \u2013 Sadece in vitro ve klinik \u00f6ncesi \u00e7al\u0131\u015fmalar i\u00e7indir.<\/span><\/span><\/strong><\/p>\n

    \n

    Dozaj ve Kullan\u0131m Talimatlar\u0131<\/span><\/span><\/strong><\/h3>\n
      \n
    • \n

      Ara\u015ft\u0131rma dozu (klinik \u00f6ncesi): <\/span><\/span><\/strong>\u00a00,1\u201310 mg\/kg<\/span><\/span><\/strong> \u00a0(modele ba\u011fl\u0131 olarak).<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Pelet \u00e7\u00f6zeltisi:<\/span><\/span><\/strong> \u00a0\u00c7\u00f6z\u00fcn\u00fcr\u00a0 <\/span><\/span>dam\u0131t\u0131lm\u0131\u015f su veya uygun bir \u00e7\u00f6z\u00fcc\u00fc<\/span><\/span><\/strong> \u00a0(\u00f6rne\u011fin PEG-400).<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Y\u00f6netim:<\/span><\/span><\/strong><\/p>\n

        \n
      • \n

        A\u011f\u0131zdan<\/span><\/span><\/strong> \u00a0(hayvan modelleri)<\/span><\/span><\/p>\n<\/li>\n

      • \n

        In vitro<\/span><\/span><\/strong> \u00a0(h\u00fccre k\u00fclt\u00fcrleri, beyin dilimleri)<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n

      • \n

        S\u0131kl\u0131k:<\/span><\/span><\/strong> \u00a0\u00c7al\u0131\u015fma tasar\u0131m\u0131na ba\u011fl\u0131 olarak tek veya tekrarlanan dozlar.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

        \ud83d\udea8\u00a0\u00d6nemli G\u00fcvenlik Notlar\u0131:<\/span><\/span><\/strong><\/p>\n

          \n
        • \n

          Hi\u00e7bir insan uygulamas\u0131 yok<\/span><\/span><\/strong> \u00a0\u2013 Uzun s\u00fcreli kullan\u0131ma ili\u015fkin yeterli g\u00fcvenlik verisi bulunmamaktad\u0131r.<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Y\u00fcksek dozlar ba\u015f a\u011fr\u0131s\u0131na veya a\u015f\u0131r\u0131 uyar\u0131lmaya neden olabilir.<\/span><\/span><\/strong><\/p>\n<\/li>\n

        • \n

          G\u00fc\u00e7l\u00fc kolinerjik veya glutamaterjik ajanlarla kombinasyondan ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/span><\/span><\/strong><\/p>\n<\/li>\n<\/ul>\n

          \n

          Dezavantajlar\u0131 ve Olas\u0131 Yan Etkileri<\/span><\/span><\/strong><\/h3>\n
            \n
          • \n

            Ba\u015f a\u011fr\u0131s\u0131<\/span><\/span><\/strong> \u00a0(a\u015f\u0131r\u0131 kolinerjik aktivite nedeniyle).<\/span><\/span><\/p>\n<\/li>\n

          • \n

            Sinirlilik veya uykusuzluk<\/span><\/span><\/strong> \u00a0hassas deneklerde.<\/span><\/span><\/p>\n<\/li>\n

          • \n

            Olas\u0131 tolerans geli\u015fimi<\/span><\/span><\/strong> \u00a0Uzun s\u00fcreli kullan\u0131mda.<\/span><\/span><\/p>\n<\/li>\n

          • \n

            S\u0131n\u0131rl\u0131 klinik veriler<\/span><\/span><\/strong> \u00a0kronik toksisite \u00fczerine.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

            \n

            S\u0131k\u00e7a Sorulan Sorular (SSS)<\/span><\/span><\/strong><\/h3>\n

            1. Noopept Hollanda'da yasal m\u0131?<\/span><\/span><\/strong><\/h4>\n

            Evet, ama sadece\u00a0 <\/span><\/span>bilimsel ama\u00e7lar<\/span><\/span><\/strong> . Afyon Yasas\u0131 kapsam\u0131na girmiyor ama onayl\u0131 bir ila\u00e7 da de\u011fil.<\/span><\/span><\/p>\n

            2. Noopept ile Piracetam aras\u0131ndaki fark nedir?<\/span><\/span><\/strong><\/h4>\n

            Noopept\u00a0 <\/span><\/span>potansiyel olarak 1000 kat daha g\u00fc\u00e7l\u00fc<\/span><\/span><\/strong> \u00a0(molar kar\u015f\u0131la\u015ft\u0131rma) ve bir\u00a0 <\/span><\/span>daha geni\u015f bir eylem yelpazesi<\/span><\/span><\/strong> , potansiyel n\u00f6rojenik etkiler de dahil olmak \u00fczere.<\/span><\/span><\/p>\n

            3. Noopept ne kadar s\u00fcre etki eder?<\/span><\/span><\/strong><\/h4>\n
              \n
            • \n

              Ba\u015flang\u0131\u00e7:<\/span><\/span><\/strong> \u00a0~15\u201330 dakika (oral).<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Tepe etkisi:<\/span><\/span><\/strong> \u00a01\u20132 saat.<\/span><\/span><\/p>\n<\/li>\n

            • \n

              S\u00fcre:<\/span><\/span><\/strong> \u00a04\u20136 saat (n\u00f6roplastisite \u00fczerinde uzun vadeli olas\u0131 etkilerle birlikte).<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

              4. Noopept di\u011fer nootropiklerle birlikte kullan\u0131labilir mi?<\/span><\/span><\/strong><\/h4>\n

              Evet, ancak a\u015fa\u011f\u0131dakilerle birle\u015ftirirken dikkatli olunmas\u0131 \u00f6nerilir:<\/span><\/span><\/p>\n

                \n
              • \n

                Kolinesteraz inhibit\u00f6rleri<\/span><\/span><\/strong> \u00a0(ba\u015f a\u011fr\u0131s\u0131 riskinin artmas\u0131).<\/span><\/span><\/p>\n<\/li>\n

              • \n

                Uyar\u0131c\u0131lar<\/span><\/span><\/strong> \u00a0(olas\u0131 a\u015f\u0131r\u0131 uyar\u0131lma).<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                \n

                Laboratuvar Raporu ve Kalite Kontrol\u00fc<\/span><\/span><\/strong><\/h3>\n
                  \n
                • \n

                  Safl\u0131k (HPLC): <\/span><\/span><\/strong>\u00a0\u226599%<\/span><\/span><\/strong><\/p>\n<\/li>\n

                • \n

                  A\u011f\u0131r metallerden, mikrobiyal kirleticilerden ve kal\u0131nt\u0131lardan ar\u0131nd\u0131r\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/strong><\/p>\n<\/li>\n

                • \n

                  Kararl\u0131 pelet form\u00fclasyonu<\/span><\/span><\/strong> \u00a0kolay dozajlama ve saklama i\u00e7in.<\/span><\/span><\/p>\n<\/li>\n

                • \n

                  Ayr\u0131nt\u0131l\u0131 parti analizi<\/span><\/span><\/strong> \u00a0ara\u015ft\u0131rma kurumlar\u0131n\u0131n kullan\u0131m\u0131na a\u00e7\u0131kt\u0131r.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

                  \n

                  \u00d6nerilen Ara\u015ft\u0131rma Senaryolar\u0131<\/span><\/span><\/strong><\/h3>\n
                    \n
                  1. \n

                    Haf\u0131za ve \u00d6\u011frenme \u00c7al\u0131\u015fmalar\u0131<\/span><\/span><\/strong> \u00a0\u2013 Hayvan Modellerinde Mekansal Haf\u0131zaya Etkileri.<\/span><\/span><\/p>\n<\/li>\n

                  2. \n

                    N\u00f6rodejeneratif Hastal\u0131klar<\/span><\/span><\/strong> \u00a0\u2013 Beta-Amiloid Plaklara Kar\u015f\u0131 Potansiyel Koruma.<\/span><\/span><\/p>\n<\/li>\n

                  3. \n

                    Elektrofizyolojik \u00c7al\u0131\u015fmalar<\/span><\/span><\/strong> \u00a0\u2013 N\u00f6ronal Uyar\u0131labilirlik ve Uzun Vadeli Potansiyasyon (LTP) \u00dczerindeki Etkisi.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

                    \ud83d\udd2c\u00a0Sadece laboratuvar kullan\u0131m\u0131 i\u00e7indir \u2013 \u0130nsan t\u00fcketimi i\u00e7in de\u011fildir!<\/span><\/span><\/strong><\/p>\n

                    \n

                    Yasal Uyar\u0131:<\/span><\/span><\/strong> \u00a0Bu \u00fcr\u00fcn\u00a0 <\/span><\/span>yaln\u0131zca bilimsel ara\u015ft\u0131rma ama\u00e7l\u0131d\u0131r<\/span><\/span><\/strong> \u00a0G\u0131da takviyesi veya ila\u00e7 olarak kullan\u0131lmamal\u0131d\u0131r. T\u00fcm deneyler, y\u00fcr\u00fcrl\u00fckteki etik ve yasal y\u00f6nergelere uygun olarak y\u00fcr\u00fct\u00fclmelidir.<\/span><\/span><\/p>","protected":false},"excerpt":{"rendered":"

                    Noopept 20 MG Pellets \u2013 Scientific Product Description General Information Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) \u00a0is a\u00a0 peptidergic nootropic compound \u00a0with<\/p>","protected":false},"featured_media":28829,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[481,501,330,324,398],"product_tag":[326],"class_list":["post-23630","product","type-product","status-publish","has-post-thumbnail","product_cat-noopept","product_cat-noopept-pellets","product_cat-nootropics","product_cat-pellets-for-pellet","product_cat-verkoop","product_tag-nl","first","instock","taxable","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/comments?post=23630"}],"version-history":[{"count":5,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23630\/revisions"}],"predecessor-version":[{"id":28061,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product\/23630\/revisions\/28061"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/media\/28829"}],"wp:attachment":[{"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/media?parent=23630"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_brand?post=23630"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_cat?post=23630"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/researchchemicalstore.eu\/tr\/wp-json\/wp\/v2\/product_tag?post=23630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}